Salvage Therapy

• 

  Subject Areas on Research

  • "Mirror-lake" serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction. 
  • 194 Efficacy of Primary Microvascular Decompression vs Salvage Microvascular Decompression for Trigeminal Neuralgia. 
  • A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). 
  • A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia. 
  • A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. 
  • A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. 
  • A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy. 
  • A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602). 
  • A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with relapsed or refractory non-small cell lung cancer. 
  • A realistic complication analysis of 70 sural artery flaps in a multimorbid patient group. 
  • ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. 
  • Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. 
  • Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. 
  • Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death. 
  • Agility to INBONE: anterior and posterior approaches to the difficult revision total ankle replacement. 
  • Alternate statistical tools and limitations in genetic marker association studies in single-arm drug cancer trials. 
  • Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. 
  • Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation. 
  • Anterior rectal wall gastrointestinal stromal tumor presenting clinically as prostatic mass. 
  • Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. 
  • Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia. 
  • Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. 
  • Autologous bone marrow transplantation for acute lymphoblastic leukemia. 
  • Available evidence on HIFU for focal treatment of prostate cancer: a systematic review. 
  • Avascular necrosis of the talus: current treatment options. 
  • Avastin: more questions than answers. . 
  • Biochemical recurrence after definitive prostate cancer therapy. Part II: treatment strategies for biochemical recurrence of prostate cancer. 
  • CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer. 
  • CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies. 
  • CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States. 
  • Calciphylaxis: a poor prognostic indicator for limb salvage. 
  • Capromab Pendetide imaging of prostate cancer. 
  • Carcinoma of the tonsillar region: a multivariate analysis of 243 patients treated with radical radiotherapy. 
  • Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease. 
  • Chemotherapy and radiation of anal canal cancer: the first approach. 
  • Clinical characteristics of testicular extramedullary involvement in multiple myeloma. 
  • Clinical trial end points for high-grade glioma: the evolving landscape. 
  • Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features. 
  • Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia. 
  • Comparison of outcomes between patients with idiopathic normal pressure hydrocephalus who received a primary versus a salvage shunt. 
  • Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. 
  • Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone. 
  • Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. 
  • Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. 
  • Diagnosis and Management of Local Recurrence After Prostate Focal Therapy: Challenges and Solutions. 
  • Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. 
  • Early Discontinuation of Breast Free Flap Monitoring: A Strategy Driven by National Data. 
  • Early salvage versus adjuvant therapy for treatment of prostate cancer following prostatectomy. 
  • Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study. 
  • Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. 
  • Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. 
  • Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma. 
  • Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. 
  • External beam radiation therapy after radical prostatectomy: efficacy and impact on urinary continence. 
  • Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma. 
  • Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen. 
  • Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia. 
  • Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients. 
  • Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. 
  • Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML. 
  • Graft versus tumor effect in the brain of a child with recurrent metastatic medulloblastoma. 
  • Guideline adjudicated fibrinolytic failure: incidence, findings, and management in a contemporary clinical trial. 
  • Head and neck cancers. 
  • High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms tumor. 
  • High dose cyclophosphamide with carboplatin: a tolerable regimen suitable for dose intensification in children with solid tumors. 
  • High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series. 
  • High-intensity focused ultrasound for focal therapy: reality or pitfall? 
  • How I treat refractory chronic graft-versus-host disease. 
  • Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates. 
  • Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms. 
  • Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer. 
  • Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. 
  • Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death. 
  • Impact of race on survival in men with metastatic hormone-refractory prostate cancer. 
  • Initiation of salvage therapy for prostate cancer. 
  • Institutional Outcomes of Leech Therapy for Venous Congestion in 87 Patients. 
  • Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure. 
  • Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. 
  • It's not always too late: a case for minimally invasive salvage esophagectomy. 
  • Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study. 
  • Laser-Assisted Indocyanine Green Dye Angiography for Postoperative Fistulas After Salvage Laryngectomy. 
  • Life-saving hemicraniectomy for fulminant acute disseminated encephalomyelitis. 
  • Long-term pegylated liposomal doxorubicin use in recurrent ovarian carcinoma. 
  • Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma. 
  • Management of Port Occlusions in Adults: Different-Site Replacement versus Same-Site Salvage. 
  • Management of extraretroperitoneal masses in germ cell tumor. 
  • Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series. 
  • Management of the patient with a rising PSA alone. 
  • Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. 
  • Meniscal Salvage: Where We Are Today. 
  • Microsurgical salvage of the intractable oral vestibule. 
  • Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer. 
  • Multiple myeloma, version 1.2013. 
  • NCCN Practice Guidelines for Acute Myelogenous Leukemia. 
  • Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. 
  • Oncologic effectiveness of selective neck dissection in the N0 irradiated neck. 
  • Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure. 
  • Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. 
  • Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients. 
  • Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. 
  • Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. 
  • Outcomes of endovascular interventions for salvage of renal transplant allografts. 
  • Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study. 
  • Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial. 
  • Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. 
  • Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia. 
  • Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98). 
  • Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma. 
  • Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer. 
  • Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207. 
  • Phase II study of carboplatin in children with progressive low-grade gliomas. 
  • Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304). 
  • Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902. 
  • Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). 
  • Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy. 
  • Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer. 
  • Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. 
  • Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy. 
  • Popliteal-to-distal bypass: identifying risk factors associated with limb loss and graft failure. 
  • Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment. 
  • Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens. 
  • Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. 
  • Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial. 
  • Primary care of HIV infection. 
  • Primary radiation therapy for early glottic cancer. 
  • Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45). 
  • Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation. 
  • Prostate specific antigen recurrence after definitive therapy. 
  • Purulent Inflatable Penile Prostheses Can Be Safely Immediately Salvaged in Insulin-Dependent Diabetics. 
  • Radical radiotherapy for T4 carcinoma of the skin of the head and neck: a multivariate analysis. 
  • Radiotherapy following radical prostatectomy. 
  • Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer. 
  • Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. 
  • Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection. 
  • Reirradiation for recurrent head and neck cancer. 
  • Reply to Frange and Leruez-Ville, "Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases". 
  • Rescue microlaryngoscopy: a protocol for utilization of four techniques in overcoming challenging exposures in microlaryngeal surgery. 
  • Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications. 
  • Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. 
  • Response to antiangiogenesis therapy in a patient with advanced adult-type testicular granulosa cell tumor. 
  • Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. 
  • Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. 
  • Revision and Salvage Management: Proceedings of the International Consensus Meeting on Cartilage Repair of the Ankle. 
  • Revision total ankle replacement: an early look at agility to INBONE. 
  • Revisiting a single day salvage conditioning following graft failure. 
  • Rising PSA in nonmetastatic prostate cancer. 
  • Rising prostate-specific antigen after primary prostate cancer therapy. 
  • Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. 
  • Role of salvage lymph node dissection in prostate cancer. 
  • SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials. 
  • Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. 
  • Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. 
  • Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer. 
  • Salivary gland malignancies: the role for chemotherapy and molecular targeted agents. 
  • Salvage C2 ganglionectomy after C2 nerve root decompression provides similar pain relief as a single surgical procedure for intractable occipital neuralgia. 
  • Salvage Focal Cryotherapy Offers Similar Short-term Oncologic Control and Improved Urinary Function Compared With Salvage Whole Gland Cryotherapy for Radiation-resistant or Recurrent Prostate Cancer. 
  • Salvage Neuroform stent-assisted coiling for recurrent giant aneurysm after waffle-cone treatment. 
  • Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze. 
  • Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study. 
  • Salvage Radiotherapy for Nodal Oligorecurrent Prostate Cancer: A Step Towards Predictive Criteria for Metastasis-Directed Therapy in Prostate Cancer? 
  • Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing? 
  • Salvage Surgery. 
  • Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients. 
  • Salvage laryngectomy and laryngopharyngectomy: Multicenter review of outcomes associated with a reconstructive approach. 
  • Salvage of a failed Keller resection arthroplasty. 
  • Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience. 
  • Salvage of the failed Keller resection arthroplasty. Surgical technique. 
  • Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach. 
  • Salvage radiation in men after prostate-specific antigen failure and the risk of death. 
  • Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. 
  • Salvage technique for treatment of periplafond tibial fractures: the modified fibula-pro-tibia procedure. 
  • Salvage therapy in Hodgkin's lymphoma. 
  • Salvaging vascular access and treatment of severe limb edema: case reports on the novel use of the hemodialysis reliable outflow vascular access device. 
  • Second-line chemotherapy for advanced hormone-refractory prostate cancer. 
  • Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906. 
  • Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival. 
  • Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206. 
  • Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. 
  • Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. 
  • Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir. 
  • Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. 
  • Successful nonoperative management of the most severe blunt renal injuries: a multicenter study of the research consortium of New England Centers for Trauma. 
  • Surgery after organ preservation therapy. Analysis of wound complications. 
  • Surgical Interventions During End-of-Life Hospitalizations in Children's Hospitals. 
  • Surgical management of vestibular schwannomas after failed radiation treatment. 
  • Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage Immunotherapy. 
  • Synovial sarcoma of the foot and ankle. 
  • Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. 
  • Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma. 
  • Testicular cancer. Clinical practice guidelines in oncology. 
  • Thalidomide as salvage therapy for chronic graft-versus-host disease. 
  • The role of Denosumab in joint preservation for patients with giant cell tumour of bone. 
  • The role of dynamic indocyanine green angiography in the diagnosis and treatment of retinal angiomatous proliferation. 
  • The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. 
  • The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. 
  • Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. 
  • Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma. 
  • Time-dose considerations in the treatment of anal cancer. 
  • Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy. 
  • Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. 
  • Treating the biochemical recurrence of prostate cancer after definitive primary therapy. 
  • Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease. 
  • Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. 
  • Unrelated donor marrow transplantation in children. 
  • Update on cryotherapy for prostate cancer in 2006. 
  • Update on intra-arterial chemotherapy for retinoblastoma. 
  • Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. 
  • Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis. 
  • Use of Letermovir for Salvage Therapy for Resistant Cytomegalovirus in a Pediatric Hematopoietic Stem Cell Transplant Recipient. 
  • Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer. 
  • Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy. 
  • Utilization of installation wound vacuum device for breast implant salvage: Approach and results. 
  • Utilization of irrigating negative pressure wound therapy for breast implant salvage: Long-term results and success. 
  • Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study. 
  • Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. 
  • Virologic response of nine therapy-experienced children receiving 64 weeks of nelfinavir salvage therapy. 
  • Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. 
  • When should we pull the trigger for post-radical prostatectomy radiotherapy? 
• 

  Keywords of People

  • Esclamado, Ramon Mitra, Richard Hall Chaney, Sr. Distinguished Professor Emeritus of Otolaryngology, Head and Neck Surgery & Communication Sciences
  • McLendon, Roger Edwin, Professor of Pathology, Pathology
  • Pang, Herbert, Adjunct Assistant Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering